Predictors of Cervical Coinfection with Multiple Human Papillomavirus Types

Cancer Epidemiology Biomarkers and Prevention

Volumn 12, Issue 10, 2003, Pages 1029-1037

  Rousseau, Marie Claude ^a   Abrahamowicz, Michal ^a,c   Villa, Luisa L ^b   Costa, Maria Cecilia ^b   Rohan, Thomas E ^d   Franco, Eduardo L ^a  

^a MCGILL UNIVERSITY   (Canada)

^b LUDWIG INSTITUTE FOR CANCER RESEARCH   (Brazil)

^c MONTREAL GENERAL HOSPITAL   (Canada)

^d ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS DNA;

ADULT; AGE; ARTICLE; CANCER GRADING; CONDYLOMA; CONTROLLED STUDY; CYTOLOGY; FEMALE; HIGH RISK PATIENT; HUMAN; INFECTION RISK; MAJOR CLINICAL STUDY; NONHUMAN; PRIORITY JOURNAL; PROSPECTIVE STUDY; RISK FACTOR; SEXUAL INTERCOURSE; SEXUALITY; SEXUALLY TRANSMITTED DISEASE; UTERINE CERVICITIS; UTERINE CERVIX CARCINOMA IN SITU; UTERINE CERVIX DYSPLASIA; WART VIRUS;

ADOLESCENT; ADULT; AGE FACTORS; BRAZIL; CERVICAL INTRAEPITHELIAL NEOPLASIA; COITUS; DNA, VIRAL; FEMALE; HUMANS; MIDDLE AGED; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; POLYMERASE CHAIN REACTION; PROSPECTIVE STUDIES; RISK FACTORS; SEXUALLY TRANSMITTED DISEASES; UTERINE CERVICAL NEOPLASMS;

EID: 0142212210     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (40)

1. IARC Working Group. Human Papillomaviruses. IARC Monographs on the evaluation of carcinogenic risks to humans, Vol. 64. Lyon: WHO, International Agency for Research on Cancer, 1995.
2. Walboomers, J. M. M., Jacobs, M. V., Manos, M. M., Bosch, F. X., Kummer, J. A., Shah, K. V., Snijders, P. J. F., Peto, J., Meijer, C., and Munoz, N. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J. Pathol., 189: 12-19, 1999.
3. Burk, R. D., Ho, G. Y. F., Beardsley, L., Lempa, M., Peters, M., and Bierman, R. Sexual behavior and partner characteristics are the predominant risk factors for genital human papillomavirus infection in young women. J. Infect. Dis., 174: 679-689, 1996.
4. Kjaer, S. K., De Villiers, E. M., Caglayan, H., Svare, E., Haugaard, B. J., Engholm, G., Christensen, R. B., Moller, K. A., Poll, P., Jensen, H., Vestergaard, B. F., Lynge, E., and Jensen, O. M. Human papillomavirus, herpes-simplex virus and other potential risk factors for cervical cancer in a high-risk area (Greenland) and a low-risk area (Denmark): a second look. Br. J. Cancer, 67: 830-837, 1993.
5. Bauer, H. M., Hildesheim, A., Schiffman, M. H., Glass, A. G., Rush, B. B., Scott, D. R., Cadell, D. M., Kurman, R. J., and Manos, M. M. Determinants of genital human papillomavirus infection in low-risk women in Portland, Oregon. Sex Transm. Dis., 20: 274-278, 1993.
6. Hildesheim, A., Gravitt, P., Schiffman, M. H., Kurman, R. J., Barnes, W., Jones, S., Tchabo, J. G., Brinton, L. A., Copeland, C., Epp, J., and Manos, M. M. Determinants of genital human papillomavirus infection in low-income women in Washington, D. C. Sex Transm. Dis., 20: 279-285, 1993.
7. Wheeler, C. M., Parmenter, C. A., Hunt, W. C., Becker, T. M., Greer, C. E., Hildesheim, A., and Manos, M. M. Determinants of genital human papillomavirus infection among cytologically normal women attending the University of New Mexico student health center. Sex Transm. Dis., 20: 286-289, 1993.
8. Franco, E. L., Villa, L. L., Ruiz, A., and Costa, M. C. Transmission of cervical human papillomavirus infection by sexual activity: differences between low and high oncogenic risk types. J. Infect. Dis., 172: 756-763, 1995.
9. Kjaer, S. K., van den Brule, A. J., Bock, J. E., Poll, P. A., Engholm, G., Sherman, M. E., Walboomers, J. M., and Meijer, C. J. Determinants for genital human papillomavirus (HPV) infection in 1000 randomly chosen young Danish women with normal Pap smear: are there different risk profiles for oncogenic and nononcogenic HPV types? Cancer Epidemiol. Biomark. Prev., 6: 799-805, 1997.
10. Rousseau, M. C., Franco, E. L., Villa, L. L., Sobrinho, J. P., Termini, L., Prado, J. M., and Rohan, T. E. A cumulative case-control study of risk factor profiles for oncogenic and nononcogenic cervical human papillomavirus infections. Cancer Epidemiol. Biomark. Prev., 9: 469-476, 2000.
11. Richardson, H., Franco, E., Pintos, J., Bergeron, J., Arella, M., and Tellier, P. Determinants of low- and high-risk cervical human papillomavirus infections in Montreal university students. Sex. Transm. Dis., 27: 79-86, 2000.
12. Giuliano, A. R., Papenfuss, M., Abrahamsen, M., and Inserra, P. Differences in factors associated with oncogenic and nononcogenic human papillomavirus infection at the United States-Mexico border. Cancer Epidemiol. Biomark. Prev., 11: 930-934, 2002.
13. Svare, E. I., Kjaer, S. K., Worm, A. M., Osterlind, A., Meijer, C. J., and van den Brule, A. J. Risk factors for genital HPV DNA in men resemble those found in women: a study of male attendees at a Danish STD clinic. Sex Transm. Infect., 78: 215-218, 2002.
14. Molano, M., Posso, H., Weiderpass, E., van den Brule, A. J., Ronderos, M., Franceschi, S., Meijer, C. J., Arslan, A., and Munoz, N. Prevalence and determinants of HPV infection among Colombian women with normal cytology. Br. J. Cancer, 87: 324-333, 2002.
15. Castellsague, X., Menendez, C., Loscertales, M. P., Kornegay, J. R., dos Santos, F., Gomez-Olive, F. X., Lloveras, B., Abarca, N., Vaz, N., Barreto, A., Bosch, F. X., and Alonso, P. Human papillomavirus genotypes in rural Mozambique. Lancet, 358: 1429-1430, 2001.
16. Ho, G. Y., Palan, P. R., Basu, J., Romney, S. L., Kadish, A. S., Mikhail, M., Wassertheil-Smoller, S., Runowicz, C., and Burk, R. D. Viral characteristics of human papillomavirus infection and antioxidant levels as risk factors for cervical dysplasia. Int. J. Cancer, 78: 594-599, 1998.
17. Herrero, R., Hildesheim, A., Bratti, C., Sherman, M. E., Hutchinson, M., Morales, J., Balmaceda, I., Greenberg, M. D., Alfaro, M., Burk, R. D., Wacholder, S., Plummer, M., and Schiffman, M. Population-based study of human papillomavirus infection and cervical neoplasia in rural Costa Rica. J. Natl. Cancer Inst. (Bethesda), 92: 464-474, 2000.
18. Fife, K. H., Cramer, H. M., Schroeder, J. M., and Brown, D. R. Detection of multiple human papillomavirus types in the lower genital tract correlates with cervical dysplasia. J. Med. Virol., 64: 550-559, 2001.
19. Levi, J. E., Kleter, B., Quint, W. G., Fink, M. C., Canto, C. L., Matsubara, R., Linhares, I., Segurado, A., Vanderborght, B., Neto, J. E., and Van Doom, L. J. High prevalence of human papillomavirus (HPV) infections and high frequency of multiple HPV genotypes in human immunodeficiency virus-infected women in Brazil. J. Clin. Microbiol., 40: 3341-3345, 2002.
20. Sasagawa, T., Basha, W., Yamazaki, H., and Inoue, M. High-risk and multiple human papillomavirus infections associated with cervical abnormalities in Japanese women. Cancer Epidemiol. Biomark. Prev., 10: 45-52, 2001.
21. van der Graaf, Y., Molijn, A., Doomewaard, H., Quint, W., van Doom, L. J., and van den Tweel, J. Human papillomavirus and the long-term risk of cervical neoplasia. Am. J. Epidemiol., 156: 158-164, 2002.
22. Bosch, F. X., Lorincz, A., Munoz, N., Meijer, C. J., and Shah, K. V. The causal relation between human papillomavirus and cervical cancer. J. Clin. Pathol. (Lond.), 55: 244-265, 2002.
23. Harro, C. D., Pang, Y. Y., Roden, R. B., Hildesheim, A., Wang, Z., Reynolds, M. J., Mast, T. C., Robinson, R., Murphy, B. R., Karron, R. A., Dillner, J., Schiller, J. T., and Lowy, D. R. Safety and immunogenicity trial in adult volunteers of a human papillomavirus 16 L1 virus-like particle vaccine. J. Natl. Cancer Inst. (Bethesda), 93: 284-292, 2001.
24. Koutsky, L. A., Ault, K. A., Wheeler, C. M., Brown, D. R., Barr, E., Alvarez, F. B., Chiacchierini, L. M., and Jansen, K. U. A controlled trial of a human papillomavirus type 16 vaccine. N. Engl. J. Med., 347: 1645-1651, 2002.
25. Franco, E., Villa, L., Rohan, T., Ferenczy, A., Petzl-Erler, M., and Matlashewski, G. Design and methods of the Ludwig-McGill longitudinal study of the natural history of human papillomavirus infection and cervical neoplasia in Brazil. Ludwig-McGill Study Group. Rev. Panam. Salud Publica, 6: 223-233, 1999.
26. Bosch, F. X., Manos, M. M., Munoz, N., Sherman, M., Jansen, A. M., Peto, J., Schiffman, M. H., Moreno, V., Kurman, R., Shah, K. V. Prevalence of human papillomavirus in cervical cancer: a worldwide perspective. International biological study on cervical cancer (IBSCC) Study Group. J. Natl. Cancer Inst. (Bethesda), 87: 796-802, 1995.
27. Bauer, H. M., Ting, Y., Greer, C. E., Chambers, J. C., Tashiro, C. J., Chimera, J., Reingold, A., and Manos, M. M. Genital human papillomavirus infection in female university students as determined by a PCR-based method. J. Am. Med. Assoc., 265: 472-477, 1991.
28. Hildesheim, A., Schiffman, M. H., Gravitt, P. E., Glass, A. G., Greer, C. E., Zhang, T., Scott, D. R., Rush, B. B., Lawler, P., Sherman, M. E., et al. Persistence of type-specific human papillomavirus infection among cytologically normal women. J. Infect. Dis., 169: 235-240, 1994.
29. Bernard, H. U., Chan, S. Y., Manos, M. M., Ong, C. K., Villa, L. L., Delius, H., Peyton, C. L., Bauer, H. M., and Wheeler, C. M. Identification and assessment of known and novel human papillomaviruses by PCR amplification, restriction fragment length polymorphisms, nucleotide sequence, and phylogenetic algorithms. J. Infect. Dis., 170: 1077-1085, 1994.
30. Mickey, R. M., and Greenland, S. The impact of confounder selection criteria on effect estimation. Am. J. Epidemiol., 129: 125-137, 1989.
31. Liang, K-Y., and Zeger, S. L. Longitudinal data analysis using generalized linear models. Biometrika, 73: 13-22, 1986.
32. Young, T. K., McNicol, P., and Beauvais, J. Factors associated with human papillomavirus infection detected by polymerase chain reaction among urban Canadian aboriginal and non-aboriginal women. Sex Transm. Dis., 24: 293-298, 1997.
33. Svare, E. I., Kjaer, S. K., Worm, A. M., Osterlind, A., Moi, H., Christensen, R. B., Meijer, C. J., Walboomers, J. M., and van den Brule, A. J. Risk factors for HPV infection in women from sexually transmitted disease clinics: comparison between two areas with different cervical cancer incidence. Int. J. Cancer, 75: 1-8, 1998.
34. Lazcano-Ponce, E., Herrero, R., Munoz, N., Cruz, A., Shah, K. V., Alonso, P., Hernandez, P., Salmeron, J., and Hernandez, M. Epidemiology of HPV infection among Mexican women with normal cervical cytology. Int. J. Cancer, 91: 412-420, 2001.
35. Schneider, A. Genital HPV infections. In: Lacey, C. (eds.). Papillomavirus Reviews: Current Research on Papillomaviruses. pp. 207-214. London: Leeds University Press, 1996.
36. Karlsson, R., Jonsson, M., Edlund, K., Evander, M., Gustavsson, A., Boden, E., Rylander, E., and Wadell, G. Lifetime number of partners as the only independent risk factor for human papillomavirus infection: a population-based study. Sex Transm. Dis., 22: 119-127, 1995.
37. Ho, G. Y. F., Burk, R. D., Klein, S., Kadish, A. S., Chang, C. J., Palan, P., Basu, J., Tachezy, R., Lewis, R., and Romney, S. Persistent genital human papillomavirus infection as a risk factor for persistent cervical dysplasia. J. Natl. Cancer Inst. (Bethesda), 87: 1365-1371, 1995.
38. Moscicki, A. B., Shiboski, S., Broering, J., Powell, K., Clayton, L., Jay, N., Darragh, T. M., Brescia, R., Kanowitz, S., Miller, S. B., Stone, J., Hanson, E., and Palefsky, J. The natural history of human papillomavirus infection as measured by repeated DNA testing in adolescent and young women. J. Pediatr., 132: 277-284, 1998.
39. Schlecht, N. F., Kulaga, S., Robitaille, J., Ferreira, S., Santos, M., Miyamura, R. A., Duarte-Franco, E., Rohan, T. E., Ferenczy, A., Villa, L. L., and Franco, E. L. Persistent human papillomavirus infection as a predictor of cervical intraepithelial neoplasia. J. Am. Med. Assoc., 286: 3106-3114, 2001.
40. Schlecht, N. F., Franco, E. L., Rohan, T. E., Kjaer, S. K., Schiffman, M. H., Moscicki, A. B., and Duffy, S. W. Repeatability of sexual history in longitudinal studies on HPV infection and cervical neoplasia: determinants of reporting error at follow-up interviews. J. Epidemiol. Biostat., 6: 393-407, 2001.